Le Lézard
Classified in: Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast

POSaBIT Reports Third Quarter 2021 Financial Results

POSaBIT Systems Corporation (CSE:PBIT, OTC:POSAF), the leading provider of payments infrastructure in the cannabis industry, today announced its financial results for the three months ended September 30, 2021.

"Our momentum continued in the third quarter with record high revenue of $6.3 million, which was up 173% year-over-year and 29% sequentially," said Ryan Hamlin, CEO and Co-founder of POSaBIT. "Based on this strong performance and our visibility into year end, we are once again raising our guidance for full year 2021 revenue to a range of $19 million to $20.5 million. At the mid-point, this represents an expectation for full-year 2021 growth of more than 158% and will continue our track record of doubling revenue every year since 2017."

Hamlin continued, "We are very confident high growth will continue, and remain on track to double head count to meet accelerated demand in the market. We also continue to invest in new product offerings, such as ?POSaBIT Kiosk,' and ?POSaBIT Cash Advance' that complement our best-in-class payments and point of sale offering and are partnering with industry leaders to increase digital payment penetration and enter new markets. We now have an established presence in 15 states in the U.S. and are pursing expansion opportunities in several more. Existing store locations are also a key growth lever for our business as retailers grow their own businesses and customers increasingly embrace cashless payment alternatives. Considering our record backlog, coupled with a rapidly growing cannabis market and multiple growth levers in our business reinforces our optimism for continued rapid growth in the fourth quarter and new year ahead."

Third Quarter 2021 Financial Highlights

Adjusted EBITDA, inclusive of a one-time adjustments of $(211) thousand was $(509) thousand compared with $(43) thousand in the third quarter of 2020. After adjusting for one-time items, Adjusted EBITDA would have been $(298) thousand. After a full strategic review, the company has determined there is more shareholder value to be created by reinvesting its profits in the business to grow market share.

Adjusted EBITDA is a non-IFRS measure used by management that does not have any prescribed meaning by IFRS and that may not be comparable to similar measures presented by other companies. The Company defines Adjusted EBITDA as net income or loss generated for the period as reported, before interest, taxes, depreciation and amortization and is further adjusted to remove changes in fair values and expected credit losses, foreign exchange gains and/or losses, impairments. The Company believes this is a useful metric to evaluate its core operating performance.

Warrants and Cash Update

As of September 30, 2021, the company had cash of approximately $5.5 million compared to approximately $1.0 million as of December 31, 2020. This increase was partially driven by approximately $3.6 million of cash received from the exercise of 18,201,410 outstanding warrants during the period. As of September 30, 2021, the Company had basic shares outstanding of 131,812,382 and fully diluted shares outstanding of 154,170,789.

Recent Operational Highlights

Financial Results

in US Dollars


Three months ended


Nine months ended



Sept. 30,



Sept. 30,





Sept. 30,



Sept. 30,

















Cost of goods sold













Gross profit













Gross profit margin






-10 %







Operating costs













Operating gain (loss)













Other expenses (income)













Loss before discontinued operations













Loss from discontinued operations













Net loss













The following table reconciles Adjusted EBITDA to net loss, as reported.



Three months ended



Sept. 30,



Sept. 30,



June 30,


Loss from continuing operations, as reported










Add back: share based compensation, as reported










Add back/(deduct): change in fair value financial instrument, as report










Add back: change in expected credit loss, as reported










Add back: depreciation and amortization, as reported










Add back: fair value of derivative instrument, as reported










Add back: disposal of assets, as reported










Deduct gain on disposal of discounted operations, as reported










Add back (deduct) finance costs, as reported










(Deduct) / add back foreign exchange (gains) / losses










Adjusted EBITDA










POSaBIT did see negative Adjusted EBITDA for the quarter ended September 30, 2021, which was expected given the investment made in additional resources to support our rapid growth

2021 Outlook

The Company provides the following revised guidance for the full year 2021.


Revised Guidance

Prior Guidance

(as of Nov. 30, 2021)

(as of July 22, 2021)




Total Revenue

$19.0M - $20.5M

$17.5M - $19.0M

Transaction sales for card services


$350M - $375M

Gross Profit Margin


28% - 32%

2022 Outlook

The Company provides the following initial guidance for the full year 2022. Previously the Company had issued guidance with its fourth quarter earnings report. However, since the company, as a Canadian filer, historically has reported fourth quarter later than most U.S. reporting companies, it wishes to provide an initial outlook here with its Q3 2021 report.




(as of Nov 30, 2021)



Total Revenue

$36.0 M - $39.5M

Conference Call Information

Date: November 30, 2021
Time: 4:30pm Eastern Time
Toll-Free: 888-506-0062
International: 973-528-0011
Entry Code: 651923
Live Webcast: https://www.webcaster4.com/Webcast/Page/2708/43450

Conference Call Replay Information:

The replay will be available approximately 1 hour after the completion of the live event.
Toll Free: 877-481-4010
International: 919-882-2331
Replay Passcode: 43450
Replay Webcast: https://www.webcaster4.com/Webcast/Page/2708/43450

Financial Reports

Full details of the financial and operating results are described in the company's consolidated financial statements with accompanying notes. The consolidated financial statements and additional information about POSaBIT are available on the company's website at www.posabit.com/investor-relations or on SEDAR at www.sedar.com.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding our business strategy, product development, timing of product development, events and courses of action.

Statements which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, outlook, expectations or intentions regarding the future including words or phrases such as "anticipate," "objective," "may," "will," "might," "should," "could," "can," "intend," "expect," "believe," "estimate," "predict," "potential," "plan," "is designed to" or similar expressions suggesting future outcomes or the negative thereof or similar variations. Forward-looking statements may include, among other things, statements about: our expectations regarding our expenses, sales and operations; our future customer concentration; our anticipated cash needs and our estimates regarding our capital requirements and our need for additional financing; our ability to anticipate the future needs of our customers; our plans for future products and enhancements of existing products; our future growth strategy and growth rate; our future intellectual property; and our anticipated trends and challenges in the markets in which we operate. Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which POSaBIT will operate in the future, including the demand for our products, anticipated costs and ability to achieve goals. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Given these risks, uncertainties and assumptions, you should not unduly rely on these forward-looking statements.

Forward-looking statements are subject to known and unknown risks, uncertainties and other important factors that may cause the actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to, business, economic and capital market conditions; the ability to manage our operating expenses, which may adversely affect our financial condition; our ability to remain competitive as other better financed competitors develop and release competitive products; regulatory uncertainties; market conditions and the demand and pricing for our products; our relationships with our customers, distributors and business partners; our ability to successfully define, design and release new products in a timely manner that meet our customers' needs; our ability to attract, retain and motivate qualified personnel; competition in our industry; our ability to maintain technological leadership; our ability to manage risks inherent in foreign operations; the impact of technology changes on our products and industry; our failure to develop new and innovative products; our ability to successfully maintain and enforce our intellectual property rights and defend third-party claims of infringement of their intellectual property rights; the impact of intellectual property litigation that could materially and adversely affect our business; our ability to manage working capital; and our dependence on key personnel. POSaBIT is an early stage company with a short operating history; it may not achieve profitability; and it may not actually achieve its plans, projections, or expectations.

Important factors that could cause actual results to differ materially from POSaBIT's expectations include consumer sentiment towards POSaBIT's products and blockchain/cryptocurrency exchange technology generally, litigation, global economic climate, loss of key employees and consultants, additional funding requirements, changes in laws, technology failures, competition, and failure of counterparties to perform their contractual obligations.

Neither we nor any of our representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release. Neither we nor any of our representatives shall have any liability whatsoever, under contract, tort, trust or otherwise resulting from the use of the information in this news release or for omissions from the information in this news release.


POSaBIT (CSE:PBIT) is a financial technology company that delivers unique and innovative, blockchain-enabled payment processing and point-of-sale systems for cash-only businesses. POSaBIT specializes in resolving pain points for complex, high-risk, emerging industries like cannabis with an all-in-one solution that is compliant, user-friendly and utilizes top-of-the-line hardware. POSaBIT's unique solution provides a safer and transparent environment for merchants while creating a better overall experience for the consumer. For additional information, visit: www.posabit.com.

These press releases may also interest you

at 06:35
ChromaDex Corp. today announced a supply agreement with Designs for Health, a U.S.-based manufacturer of premium dietary supplements for healthcare practitioners (HCPs). ChromaDex's proprietary healthy aging ingredient Niagen®, the world's first and...

at 06:30
The latest market research report, "Smart City Market by Application and Geography - Forecast and Analysis 2021-2025" by Technavio infers that the increase in IT consolidation and modernization is driving the smart city market's growth. The market...

at 06:30
Leading autonomous driving computing chip maker Black Sesame Technologies (Black Sesame) has selected BlackBerry® QNX® technology to power its latest chipset developed for autonomous driving. The combination of the BlackBerry and Black Sesame...

at 06:30
Flagstar Bancorp, Inc. , the holding company for Flagstar Bank, FSB, today announced its board of directors has declared a quarterly cash dividend of $0.06 per share on its common stock. The dividend will be payable February 17, 2022, to shareholders...

at 06:30
Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced clinical trial recruitment findings from the CRC-PREVENT pivotal trial evaluating the safety and efficacy of its...

at 06:30
ZielBio, Inc., a clinical stage biotechnology company discovering new treatments for cancer and other serious diseases through its innovative ZielFind drug discovery platform, welcomes Maria Beconi, Ph.D., as the company's chief science officer, and...

News published on 30 november 2021 at 16:10 and distributed by: